BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16897363)

  • 1. Giant cells: contradiction to two-hit model of tuber formation?
    Jozwiak J; Jozwiak S
    Cell Mol Neurobiol; 2007 Mar; 27(2):251-61. PubMed ID: 16897363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cells: contradiction to two-hit model of tuber formation?
    Jozwiak J; Jozwiak S
    Cell Mol Neurobiol; 2005 Aug; 25(5):795-805. PubMed ID: 16133934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB; Aronica E; Baltuch G; Nathanson KL
    Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of tuberous sclerosis complex (TSC) protein function in the brain.
    Ramesh V
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):579-83. PubMed ID: 12773159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
    Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
    Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
    Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
    Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
    Boer K; Troost D; Jansen F; Nellist M; van den Ouweland AM; Geurts JJ; Spliet WG; Crino P; Aronica E
    Neuropathology; 2008 Dec; 28(6):577-90. PubMed ID: 18410267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for population variation in TSC1 and TSC2 gene expression.
    Jentarra GM; Rice SG; Olfers S; Saffen D; Narayanan V
    BMC Med Genet; 2011 Feb; 12():29. PubMed ID: 21345208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis.
    Jozwiak J; Jozwiak S; Skopinski P
    Histol Histopathol; 2005 Oct; 20(4):1321-6. PubMed ID: 16136513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
    Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber.
    Jansen FE; Notenboom RG; Nellist M; Goedbloed MA; Halley DJ; de Graan PN; van Nieuwenhuizen O
    Neurology; 2004 Oct; 63(7):1293-5. PubMed ID: 15477556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin.
    Kim SH; Speirs CK; Solnica-Krezel L; Ess KC
    Dis Model Mech; 2011 Mar; 4(2):255-67. PubMed ID: 20959633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.